InvestorsHub Logo

gastric

02/18/18 11:54 AM

#175452 RE: varok #175451

RS without the theoretical billions of assets everyone has been patiently waiting to get rolled in will totally kill this.

Erd03d

02/18/18 12:27 PM

#175456 RE: varok #175451

I like your thinking, I'm with you.

joma

02/18/18 12:48 PM

#175457 RE: varok #175451

Varok thanks for bringing some sanity back, i am with you,very good post

BMOC91324

02/18/18 1:20 PM

#175461 RE: varok #175451

Good post Varok...

How can the company meet the 1.25 billion O/S minimum nasdaq requirement when the preferred shares are convertible to 1.25 billion, there will be 8 milliom common shares post split, and there are only 2 billion A/S?... will the company need to dilute 1.242 billion shares to make up the difference? Thanks in advance ( :

SniperStocks

02/18/18 1:26 PM

#175462 RE: varok #175451

well said, good knowledge here

billy spec

02/18/18 1:42 PM

#175468 RE: varok #175451

I don't think Wang is stupid, he has to dilute, and do split for his benefit, so I think we may see a bid dip next week below .012 and then we load up.

daveymoore

02/18/18 4:37 PM

#175485 RE: varok #175451

agree with most of this but don't anticipate post split sell off; time will tell; good to see Varok back

Nelly 15

02/18/18 5:08 PM

#175492 RE: varok #175451

Couldn't agree more. I sold all my remaining shares on the news of RS but will be looking to acquire my position again post split. The company will need to release some major news or spectacular fins to combat the price drop that happens when RS takes place and the shorting that usual takes place RS.

Which I do believe the company does have something up their sleeve but will not release anything till post split IMO...

GLTA and I am looking forward to having a position in JBZY again in the future.

Nelly

LaFortuna

02/18/18 5:17 PM

#175493 RE: varok #175451

We agree with most if not all your speculative comments.

We typically invest in listed biotechs, but have modified our portfolio to include four OTC stocks. One, a Crypto company now, conducted a reverse merger and very successful R/S. We are up 300% and the stock will up list later this year. The other two are soon-to-be Crypto company's which have done R/S first and now we anticipate the R/M's.

The last is JBZY. We own VERY significant holdings in this stock after conducting our own DD. Why, we believe that China will dominate the EV market. Our informal investment club expected an R/S, but not 1-100. We have not sold a single share.

The other issue which has not been discussed is the so-called Cusip change chatter last week. We would like to point out....

A stock split changes the number of shares and the price per share, but does not change your position's total value. With a reverse split, the number of shares is decreased while the price per share is increased. ... Tip: When a stock has a reverse split, it always changes its CUSIP ID and may change its symbol too.

We have long-time contacts in two major brokerage firms and the two databases they use have not shown a Cusip change yet. Some on this board showed proof of a Cusip change. If a new Cusip has been issued, the R/S is already approved by FINRA. We believe that the approval by FINRA is complete assuming a new CUSIP has been issued.

Every positive post written on this board is now contingent on one and one document only, an audited financial document showing assets of a billion(s) EV company. We expect this to be filed in the next six weeks, if not we exit, take a loss to offset our gains in 2018!